Contrary to popular perception, men who take hormone replacement medication to address declining testosterone levels are not exposed to a higher risk of developing prostate cancer.
This is the conclusion by a team of researchers who conducted an extensive analysis of medical records at the National Prostrate Cancer Register and the Prescribed Drug Register in Sweden. According to a news release, the study revealed that the male patients who underwent testosterone replacement therapy (TRT) for over a year had lowered their risk of aggressive disease by about fifty percent.
According to co-author and lead researcher Stacy Loeb, a urologist at the NYU Langone Medical Center, the findings support the position that maintaining testosterone levels within a normal range is crucial for the overall health of aging men. She says that men who have low testosterone and experience the associated symptoms should consult their doctors to determine whether or not testosterone replacement should be resorted to.
When used properly, the therapy can significantly reverse the symptoms of low testosterone, which include reduced libido, fatigue, depression, weight gain, and mood swings. Administering the treatment at the right doses can improve the patients’ sexual health, mood, and quality of life.
[Photo from Day Donaldson via Flickr]